Literature DB >> 21175165

Characterization of differences between blood sample matrices in untargeted metabolomics.

Judith R Denery1, Ashlee A K Nunes, Tobin J Dickerson.   

Abstract

Large-scale proteomic and metabolomic technologies are increasingly gaining attention for their use in the diagnosis of human disease. In order to ensure the statistical power of relevant markers, such analyses must incorporate a large number of representative samples. While in a best-case scenario these samples are collected through a study design that is specifically tailored for the desired analysis, often studies must rely upon the analysis of large numbers of previously banked samples that may or may not have complete and accurate documentation of their associated collection and storage methods. In this study, several human blood matrices were analyzed and compared for the quality of metabolomic output. The sample types that were tested include plasma prepared with a variety of anticoagulants and serum collected by venipuncture and capillary blood collection protocols. Analysis with liquid chromatography-mass spectrometry (LC-MS) revealed only subtle differences between the various plasma preparation methods. Differences between the serum and plasma samples appear to be largely peptide/protein-based and are consistent with the biological distinction of the two matrices. Interestingly, the small molecule lysophosphatidylinositol was found to be in higher abundance in plasma, as a possible consequence of the effect of the intrinsic clotting cascade on adjacent metabolic pathways. Comparison of the small-molecule profiles of the capillary- and venipuncture-collected samples revealed 23 statistically significant compound differences between these sample types. Most of these features can be attributed to surfactants and detergents used to pretreat the skin in order to maintain the sterility of sample collection. However, several have identical mass and molecular formulas as endogenous human metabolites and could be erroneously attributed to actual metabolic perturbations. Understanding the extent of these matrix effects is important for control of systematic bias and ensuring the quality of metabolomic analysis.

Entities:  

Mesh:

Year:  2010        PMID: 21175165     DOI: 10.1021/ac102806p

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  22 in total

1.  Chronic caloric restriction partially protects against age-related alteration in serum metabolome.

Authors:  Jennifer M De Guzman; Ginger Ku; Ryan Fahey; Yun-Hee Youm; Ignatius Kass; Donald K Ingram; Vishwa Deep Dixit; Indu Kheterpal
Journal:  Age (Dordr)       Date:  2012-06-04

2.  Biobanking and international interoperability: samples.

Authors:  Michael Kiehntopf; Michael Krawczak
Journal:  Hum Genet       Date:  2011-07-15       Impact factor: 4.132

3.  A comparison of human serum and plasma metabolites using untargeted 1H NMR spectroscopy and UPLC-MS.

Authors:  Manuja Kaluarachchi; Claire L Boulangé; Ibrahim Karaman; John C Lindon; Timothy M D Ebbels; Paul Elliott; Russell P Tracy; Nels C Olson
Journal:  Metabolomics       Date:  2018-02-13       Impact factor: 4.290

4.  Serum proteome changes in dengue virus-infected patients from a dengue-endemic area of India: towards new molecular targets?

Authors:  Sandipan Ray; Rajneesh Srivastava; Karnika Tripathi; Vineet Vaibhav; Swati Patankar; Sanjeeva Srivastava
Journal:  OMICS       Date:  2012-08-23

Review 5.  The use of mass spectrometry for analysing metabolite biomarkers in epidemiology: methodological and statistical considerations for application to large numbers of biological samples.

Authors:  Mads V Lind; Otto I Savolainen; Alastair B Ross
Journal:  Eur J Epidemiol       Date:  2016-05-26       Impact factor: 8.082

6.  Plasma Metabolomic Markers of Insulin Resistance and Diabetes and Rate of Incident Parkinson's Disease.

Authors:  Samantha Molsberry; Kjetil Bjornevik; Katherine C Hughes; Zhongli Joel Zhang; Sarah Jeanfavre; Clary Clish; Brian Healy; Michael Schwarzschild; Alberto Ascherio
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

Review 7.  Promises and pitfalls of untargeted metabolomics.

Authors:  Ilya Gertsman; Bruce A Barshop
Journal:  J Inherit Metab Dis       Date:  2018-03-13       Impact factor: 4.982

8.  Lipid mediator serum profiles in asthmatics significantly shift following dietary supplementation with omega-3 fatty acids.

Authors:  Susanna L Lundström; Jun Yang; John D Brannan; Jesper Z Haeggström; Bruce D Hammock; Parameswaran Nair; Paul O'Byrne; Sven-Erik Dahlén; Craig E Wheelock
Journal:  Mol Nutr Food Res       Date:  2013-07-04       Impact factor: 5.914

9.  Endocannabinoids as potential biomarkers: It's all about pre-analytics.

Authors:  Daniel Kratz; Dominique Thomas; Robert Gurke
Journal:  J Mass Spectrom Adv Clin Lab       Date:  2021-11-10

10.  Feasibility of identifying the tobacco-related global metabolome in blood by UPLC-QTOF-MS.

Authors:  Ping-Ching Hsu; Bin Zhou; Yi Zhao; Habtom W Ressom; Amrita K Cheema; Wallace Pickworth; Peter G Shields
Journal:  J Proteome Res       Date:  2013-01-14       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.